Arcturus Therapeutics Faces Volatile Stock and Profit Challenges Amid RNA‑Therapy Push
Arcturus Therapeutics, a San Diego‑based RNA‑therapeutics pioneer, faces steep stock volatility and negative P/E, questioning its path to profitable growth.
- ARCTURUS THERAPEUTICS HOLDIN
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read